Anika Therapeutics, Inc. (ANIK) Free cash flow 2016–2025
Anika Therapeutics, Inc. (ANIK) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$4.4MFY2025 · since FY2016: $10.4M → $4.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.4M | +287.1% |
| FY2024 | -$2.3M | +67.7% |
| FY2023 | -$7.2M | -134.5% |
| FY2022 | -$3.1M | -194.6% |
| FY2021 | $3.3M | -71.5% |
| FY2020 | $11.4M | -66.5% |
| FY2019 | $34.2M | +12.9% |
| FY2018 | $30.3M | -4.9% |
| FY2017 | $31.8M | +205.1% |
| FY2016 | $10.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ANIK financial trends
ANIK RevenueANIK Net incomeANIK Net marginANIK Gross profitANIK Gross marginANIK Operating incomeANIK Operating marginANIK Operating cash flowANIK Capital expendituresANIK Return on equityANIK Stock buybacksANIK Dividends paidANIK Total assetsANIK Total liabilitiesANIK Shareholders’ equityANIK overview →